Fructose-induced metabolic reprogramming of cancer cells

被引:4
|
作者
Ting, Kenneth K. Y. [1 ,2 ]
机构
[1] Univ Toronto, Dept Immunol, Toronto, ON, Canada
[2] Univ Hlth Network, Toronto Gen Hosp Res Inst, Toronto, ON, Canada
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
基金
加拿大健康研究院;
关键词
fructose; cancer; metabolic reprogramming; tumor microenvironment (TME); ketohexokinase (KHK); GLUT5; metabolism; glycolysis; DIETARY FRUCTOSE; CORN SYRUP; GLUCOSE; TRANSPORTER; GLUT2; EXPRESSION; RESISTANCE; PHENOTYPE; DRIVES;
D O I
10.3389/fimmu.2024.1375461
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Excess dietary fructose consumption has been long proposed as a culprit for the world-wide increase of incidence in metabolic disorders and cancer within the past decades. Understanding that cancer cells can gradually accumulate metabolic mutations in the tumor microenvironment, where glucose is often depleted, this raises the possibility that fructose can be utilized by cancer cells as an alternative source of carbon. Indeed, recent research has increasingly identified various mechanisms that show how cancer cells can metabolize fructose to support their proliferating and migrating needs. In light of this growing interest, this review will summarize the recent advances in understanding how fructose can metabolically reprogram different types of cancer cells, as well as how these metabolic adaptations can positively support cancer cells development and malignancy.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Carotenoids Inhibit Fructose-Induced Inflammatory Response in Human Endothelial Cells and Monocytes
    Lin, Ping
    Ren, Qian
    Wang, Qin
    Wu, Jiali
    MEDIATORS OF INFLAMMATION, 2020, 2020
  • [22] Fructose-Induced mTORC1 Activation Promotes Pancreatic Cancer Progression through Inhibition of Autophagy
    Cui, Yanfen
    Tian, Jianfei
    Wang, Zhaosong
    Guo, Hui
    Zhang, He
    Wang, Zhiyong
    Liu, Hui
    Song, Weijie
    Liu, Liming
    Tian, Ruinan
    Zuo, Xiaoyan
    Ren, Sixin
    Niu, Ruifang
    Zhang, Fei
    CANCER RESEARCH, 2023, 83 (24) : 4063 - 4079
  • [23] EFFECTS OF LACTOBACILLUS PLANTARUM ON THE AKT/ENOS CARDIAC PATHWAY IN RATS WITH FRUCTOSE-INDUCED METABOLIC SYNDROME
    Kursun, Oznur Ece Durmaz
    Yalim, Goknur
    Demirel, Murside Ayse
    Erten, Fusun
    Sahin, Kazim
    Akar, Fatma
    ACTA SCIENTIARUM POLONORUM-TECHNOLOGIA ALIMENTARIA, 2025, 24 (01) : 145 - 156
  • [24] Fructose-Induced Metabolic Dysfunction Is Dependent on the Baseline Diet, the Length of the Dietary Exposure, and Sex of the Mice
    Fadhul, Taghreed
    Park, Se-Hyung
    Ali, Heba
    Alsiraj, Yasir
    Wali, Jibran A.
    Simpson, Stephen J.
    Softic, Samir
    NUTRIENTS, 2025, 17 (01)
  • [25] Aldolase B-Mediated Fructose Metabolism Drives Metabolic Reprogramming of Colon Cancer Liver Metastasis
    Bu, Pengcheng
    Chen, Kai-Yuan
    Xiang, Kun
    Johnson, Christelle
    Crown, Scott B.
    Rakhilin, Nikolai
    Ai, Yiwei
    Wang, Lihua
    Xi, Rui
    Astapova, Inna
    Han, Yan
    Li, Jiahe
    Barth, Bradley B.
    Lu, Min
    Gao, Ziyang
    Mines, Robert
    Zhang, Liwen
    Herman, Mark
    Hsu, David
    Zhang, Guo-Fang
    Shen, Xiling
    CELL METABOLISM, 2018, 27 (06) : 1249 - +
  • [26] Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis
    Shepherd, Emma L.
    Saborano, Raquel
    Northall, Ellie
    Matsuda, Kae
    Ogino, Hitomi
    Yashiro, Hiroaki
    Pickens, Jason
    Feaver, Ryan E.
    Cole, Banumathi K.
    Hoang, Stephen A.
    Lawson, Mark J.
    Olson, Matthew
    Figler, Robert A.
    Reardon, John E.
    Nishigaki, Nobuhiro
    Wamhoff, Brian R.
    Guenther, Ulrich L.
    Hirschfield, Gideon
    Erion, Derek M.
    Lalor, Patricia F.
    JHEP REPORTS, 2021, 3 (02)
  • [27] Metabolic reprogramming in cancer: Unraveling the role of glutamine in tumorigenesis
    Daye, Dania
    Wellen, Kathryn E.
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2012, 23 (04) : 362 - 369
  • [28] Metabolic Reprogramming in Gastric Cancer: Trojan Horse Effect
    Bin, Yu-Ling
    Hu, Hong-Sai
    Tian, Feng
    Wen, Zhen-Hua
    Yang, Mei-Feng
    Wu, Ben-Hua
    Wang, Li-Sheng
    Yao, Jun
    Li, De-Feng
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [29] Effects of TNF-α antagonist infliximab on fructose-induced metabolic syndrome in rats
    Abdelhamid, Yasmine A.
    Elyamany, Mohammed F.
    Al-Shorbagy, Muhammad Y.
    Badary, Osama A.
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2021, 40 (05) : 801 - 811
  • [30] Role of activating transcription factor 3 in fructose-induced metabolic syndrome in mice
    Chou, Chu-Lin
    Li, Ching-Hao
    Lin, Heng
    Liao, Mei-Hui
    Wu, Chin-Chen
    Chen, Jin-Shuen
    Sue, Yuh-Mou
    Fang, Te-Chao
    HYPERTENSION RESEARCH, 2018, 41 (08) : 589 - 597